Slideshow

Persistent Palpitations and Dyspnea in a Middle-aged Man

Author(s):

Brady Pregerson, MD

Patient history includes right heart failure due to sinus venosus defect with anomalous right pulmonary venous return; surgical repair performed ca 2006.

Related Videos
Experts' Perspectives: Top Stories in Cardiology for 2024
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
Related Content
| Image Credit: North American Thrombosis Forum
January 23rd 2025

Christian T. Ruff, MD, MPH: Abelacimab Limits Bleeding Events in AZALEA–TIMI 71 Trial

Christian T. Ruff, MD, MPH Abigail Brooks, MA Connor Iapoce
Diabetes Dialogue: News and Updates in Diabetes at AHA 2024
November 21st 2024

Diabetes Dialogue: News and Updates in Diabetes at AHA 2024

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
National Trends in Preventive Aspirin Use Shaped by ASCVD Risk | Image Credit: University of Pittsburgh
January 22nd 2025

National Trends in Preventive Aspirin Use Shaped by ASCVD Risk

Connor Iapoce
Kidney Compass default thumbnail with podcast logo and headshots of hosts Brendon Neuen and Shikha Wadhwani.
October 28th 2024

Kidney Compass: FLOW Insights from Kidney Week 2024, with Katherine Tuttle, MD

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
FDA Accepts Plozasiran NDA for Familial Chylomicronemia Syndrome | Image Credit: US Food and Drug Administration
January 20th 2025

FDA Accepts Plozasiran NDA for Familial Chylomicronemia Syndrome

Connor Iapoce
Seonkyeong Yang, PhD I Credit: University of Florida
January 15th 2025

Anti-CGRP mAbs Are Not Linked to Increased CVD Risk in Adults with Migraine

Chelsie Derman
© 2025 MJH Life Sciences

All rights reserved.